Dangers of synthetic cannabinoids (bonzai): A case report
Sentetik kannabinoid (bonzai) kullanımının tehlikeleri: Olgu sunumu
Abstract views: 121 / PDF downloads: 40
DOI:
https://doi.org/10.5152/EurJTher.2016.009Keywords:
Synthetic cannabinoids, bonzai, generalized epileptic seizureAbstract
Cannabis has become the most widely consumed illicit substance worldwide. Synthetic cannabinoids (SCs), known mostly as JWH agents, were found to have 2-100 times more potent than THC. These are obtained with very minor modifications on the original cannabinoid compound with varying chances to be detected in routine toxicological screens. Recently the use of SCs known as Bonzai has increased considerably and SC-related deaths have increased a lot. We present a male patient who was hospitalized with the history of SC (bonzai) abuse for 3 months and started to have convulsions after using SC and brought to emergency department with chest pain and loosing consciousness immediately after using SC 1 month ago. His toxicological analysis revealed no sign of illicit drugs. EEG showed paroxysmal slow waves with sharp characteristics in both hemispheres. Mortality due to SCs may be related to sudden cardiac death in the acute phase which may result from the stimulation of sympathetic nervous system and epileptic abnormalities may be due to inhibition of γ-aminobutyric acid (GABA) neurotransmission. Novel generalized seizures and chest pain especially in young people should be warning for neurologists and cardiologists in terms of potential SC abuse.
Metrics
References
Ashton CH. Pharmacology and effects of cannabis: a brief review. Br J Psychiatry 2001;178:101-6
Alexander A, Smith PF, Rosengren RJ. Cannabinoids in the treatment of cancer. Cancer Lett 2009;285(1):6-12.
Castaneto MS, Gorelick DA, Desrosiers NA, Hartman RL, Pirard S, Huestis MA. Synthetic cannabinoids: Epidemiology, pharmacodynamics, and clinical implications. Drug Alcohol Depend 2014; pii: S0376-8716(14)01033-3.
Favretto D, Pascali JP, Tagliaro F. New challenges and innovation in forensic toxicology: focus on the “New psychoactive substances.” Chromatogr A 2013;1287:84-95.
Gurdal F, Asirdizer M, Aker RG, Korkut S, Gocer Y, Kucukibrahimoglu EE, et al. Review of detection frequency and type of synthetic cannabinoids in herbal compounds analyzed by Istanbul Narcotic Department of the Council of Forensic Medicine Turkey. J Forensic Leg Med 2013;20(6):667-72.
UNODC (2013) The challenge of new psychoactive substances. http://www.unodc.org/documents/scientific/NPS_2013_SMART.pdf Accessed 1 Feb 2014.
Thomas G, Kloner RA, Rezkalla S. Adverse cardiovascular, cerebrovascular, and peripheral vascular effects of marijuana inhalation: what cardiologists need to know. Am J Cardiol 2014;113(1):187-90.
Van Amsterdam J, Brunt T, van den Brink W. The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects. J Psychopharmacol 2015; pii: 0269881114565142.
Chneir AB, Cullen J, Ly BT. “Spice” girls: Synthetic cannabinoid intoxication. J Emerg Med 2011;40(3):296-9.
McKeever RG, Vearrier D, Jacobs D, LaSala G, Okaneku J, Greenberg MI. K2-Not the spice of life; synthetic cannabinoids and ST elevation myocardial infarction: a case report. J Med Toxicol 2014; doi: 10.1007/s13181-014-0424-1.
Aryana A, Williams MA. “Marijuana as a trigger of cardiovascular events: speculation or scientific certainty?” International Journal of Cardiology 2007;118(2):141-4.
Harris CR, Brown A. Synthetic cannabinoid intoxication: A case series and review. J Emerg Med 2013;44(2):360-6.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 European Journal of Therapeutics
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The content of this journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.